Download the PDF version here!
Cervical Cancer
- In 2025, an estimated 13,820 new cases of invasive cervical cancer will be diagnosed in women in the US.
- This year, an estimated 4,360 women will die from cervical cancer in the US.
- Cervical Cancer is most common in women 35-44 years old, average diagnosis is 50. Cervical cancer rates have declined in women ages 20–24 (−11% annually) due to HPV vaccine impact.
- Incidence has dropped by more than half since the 1970s due to screening and HPV vaccination.
- A GYN appointment takes about half an hour.
Disparities:
- Incidence of cervical cancer is 50% higher in American Indian/Alaska Native, 30% higher in Hispanic, and 22% higher in Black women compared to White women.
- Mortality rates for Black and Native American women are about 65% higher than for White women.
Modifiable Risk Factors include:
- Persistent infection with high-risk HPV is responsible for almost all cervical cancers. Early sexual activity and multiple sexual partners increase exposure to HPV.
- Obesity & physical inactivity
- Smoking
- Alcohol use (even moderate intake increases risk)
American Cancer Society Recommended Cervical Cancer Screenings:
- Ages 25–65 – Primary HPV test every 5 years (preferred)
- If HPV test not available:
- Co-testing every 5 years OR
- Pap test alone every 3 years
Stop screening
- After age 65 if regular screening in past 10 years and no CIN2+ in past 25 years
- After hysterectomy if cervix is removed and no history of cervical cancer or serious precancer
This is part 5 of a series on specific Cancers that have preventive screenings. Stay tuned to find out more about each of the 6 cancers.
To View All Parts Click Here!
Written by: Kelly McCall, Manager Health Intelligence Analytics